Buying Keytruda for Cancer Treatment, Fast And Reliablle

$4,400.00$8,000.00

Type of economic evaluation Cost-utility analysis based on a Markov Model
Target population Patients with high-risk, early-stage, triple-negative breast cancer (TNBC)
Treatments Pembrolizumab regimen: in combination with chemotherapy as neoadjuvant therapy followed by pembrolizumab as a single agent as adjuvant therapy
Submitted price Pembrolizumab, 100 mg, solution: $4,400.00 per 100 mg/4 mL vial for IV infusion
Treatment cost At the sponsor-submitted price, the additional cost of pembrolizumab in the neoadjuvant and adjuvant setting is $11,733 per 28 days (fixed dose of 200 mg every 21 days)